Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lorlatinib overcomes alectinib-induced hemolytic anemia in an ALK fusion positive non-small-cell lung cancer patient with severe tumor-associated liver failure: A case report.
Kunimasa K, Miyazaki A, Tamiya M, Inoue T, Kawamura T, Tanaka T, Futamura S, Komuta K, Nagata S, Honma K, Ohkawa K, Nishino K. Kunimasa K, et al. Among authors: tamiya m. Thorac Cancer. 2024 Dec;15(36):2570-2574. doi: 10.1111/1759-7714.15487. Epub 2024 Nov 11. Thorac Cancer. 2024. PMID: 39527462 Free PMC article.
Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan.
Asami K, Kawahara M, Hirashima T, Suzuki H, Okishio K, Omachi N, Tamiya M, Tamiya A, Hirooka A, Nakao K, Tsuji T, Atagi S. Asami K, et al. Among authors: tamiya a, tamiya m. Thorac Cancer. 2014 Jul;5(4):289-96. doi: 10.1111/1759-7714.12091. Epub 2014 Jul 3. Thorac Cancer. 2014. PMID: 26767015 Free PMC article.
Correlation of Radiation Pneumonitis History Before Nivolumab with Onset of Interstitial Lung Disease and Progression-free Survival of Patients with Pre-treated Advanced Non-small Cell Lung Cancer.
Tamiya A, Tamiya M, Nakahama K, Taniguchi Y, Shiroyama T, Isa SI, Inoue T, Okishio K, Nishino K, Kumagai T, Suzuki H, Hirashima T, Imamura F, Atagi S. Tamiya A, et al. Among authors: tamiya m. Anticancer Res. 2017 Sep;37(9):5199-5205. doi: 10.21873/anticanres.11943. Anticancer Res. 2017. PMID: 28870955
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer.
Shiroyama T, Suzuki H, Tamiya M, Tamiya A, Tanaka A, Okamoto N, Nakahama K, Taniguchi Y, Isa SI, Inoue T, Imamura F, Atagi S, Hirashima T. Shiroyama T, et al. Among authors: tamiya a, tamiya m. Cancer Med. 2018 Jan;7(1):13-20. doi: 10.1002/cam4.1234. Epub 2017 Nov 18. Cancer Med. 2018. PMID: 29150906 Free PMC article.
203 results